75
Participants
Start Date
April 12, 2018
Primary Completion Date
June 12, 2019
Study Completion Date
June 12, 2019
Mesdopetam (IRL790)
Mesdopetam (IRL790) capsule
Sahlgrenska University hospital, Gothenburg
University hospital, Linköping
University hospital, Lund
Karolinska University hospital, Stockholm
Bristol Brain Centre, Southmead Hospital, Bristol
Fairfield General Hospital (Pennine Acute NHS Trust), Bury
Ninewells Hospital, Dundee
Lincoln County Hospital, Lincoln
Charing Cross Hospital, Imperial College Healthcare NHS Trust, London
The National Hospital of Neurology and Neurosurgery (UCL), London
Luton and Dunstable University Hospital NHS Foundation Trust, Luton
North Tyneside General Hospital, North Shields
Qeens' Medical Centre, Nottingham
John Radcliffe Hospital, Oxford
Peterborough City Hospital, Peterborough
Queens's Hospital, Romford
Royal Stoke University Hospital, Stoke-on-Trent
Torbay hospital, Torquay
Royal Cornwall Hospital, Truro
Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth
Lead Sponsor
The Clinical Trial Company
INDUSTRY
Integrative Research Laboratories AB
INDUSTRY